Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

All Edhec indices positive in April except for Short-Selling (-2.95%, -8.5% YTD), Distressed Securities best performer so far (2.49%, 8.3% YTD)

Tuesday, May 18, 2010
Opalesque Industry Update - After the elation of the previous month, the stock market exhibited more cautious optimism in April as the S&P 500 index rose again (+1.58%) but displayed implied volatility (22.05%) that was slightly on the rise and above the 20% mark.

The commodities market achieved a third consecutive month of remarkable gains (+3.73%). On the fixed-income market, the Lehman Global Bond index managed a solid profit (+1.05%) as regular bonds (+0.66%) outperformed convertible bonds (+0.64%). The latter were unable to reproduce their excellent score in March. The growth of the credit spread (+0.44%) remained positive. On the money market, the dollar accelerated its ascent (+0.59%) to its highest level since June 2009.

All hedge-fund strategies benefited from this favourable situation.

Unaffected by the recovery in the stock market and sustained by the increasing credit spread and profitable convertible bonds, the Convertible Arbitrage strategy continued its post-crash trend and registered yet another solid gain (+2.13%). The CTA Global strategy (+1.15%) managed a third consecutive month of positive returns, in line with its long-term correlation to the regular bonds and commodities. The increase of the credit spread maintained the very significant profitability of the Distressed Securities strategy (+2.49%) which managed a thirteenth month of continuous gains.

The Equity Market Neutral strategy registered a modest performance (+0.30%) but completed a full semester of profitability. The Long/Short Equity strategy managed a more consistent profit (+1.06%) which brought it close to its highest level of October 2007. Finally, with a considerable gain (+1.82%) which outperformed the S&P 500 index, the Event Driven strategy achieved a fourteenth month of profitability and pushed its highest level even further.

Overall, the Fund of Funds strategy recorded an above average performance (+0.95%).


EDHEC-Risk Institute - Hedge Fund Strategies

April 2010

YTD

Convertible Arbitrage

2.13%

5.4%

CTA Global

1.15%

2.0%

Distressed Securities

2.49%

8.3%

Emerging Markets

1.33%

4.6%

Equity Market Neutral

0.30%

1.9%

Event Driven

1.82%

6.2%

Fixed Income Arbitrage

1.09%

4.5%

Global Macro

0.86%

2.2%

Long/Short Equity

1.06%

3.8%

Merger Arbitrage

0.40%

2.6%

Relative Value

1.29%

4.3%

Short Selling

-2.95%

-8.5%

Funds of Funds

0.95%

2.4%


www.edhec-risk.com


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its